The German Solution: Pseudonymization and Data Aggregation
To overcome the stringent regulatory hurdles imposed by GDPR, pharmaceutical advertisers in Germany rely heavily on advanced data governance frameworks, making pseudonymization a key technology segment within the Big Data market. Creating Anonymous Insights Instead of using individual patient records, pharma companies and their data partners (like IQVIA) focus on: Data Aggregation: Combining...
0 Commenti 0 condivisioni 13 Views 0 Anteprima
Cryell https://cryell.com